These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25338765)

  • 21. Hypogonadism and diabetes.
    Betancourt-Albrecht M; Cunningham GR
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.
    Traish AM; Saad F; Guay A
    J Androl; 2009; 30(1):23-32. PubMed ID: 18772488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
    Gianatti EJ; Dupuis P; Hoermann R; Zajac JD; Grossmann M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3821-8. PubMed ID: 24978674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study.
    Li JY; Zhu JC; Dou JT; Bai WJ; Deng SM; Li M; Huang W; Jin H
    Aging Male; 2002 Mar; 5(1):47-51. PubMed ID: 12040975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes.
    Kapoor D; Clarke S; Channer KS; Jones TH
    Int J Androl; 2007 Dec; 30(6):500-7. PubMed ID: 18028199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.
    Corrales JJ; Almeida M; Burgo R; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 2006 Jun; 189(3):595-604. PubMed ID: 16731790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome in newly diagnosed type 2 diabetes mellitus using NCEP-ATP III, the Nnewi experience.
    Osuji CU; Nzerem BA; Dioka CE; Onwubuya EI
    Niger J Clin Pract; 2012; 15(4):475-80. PubMed ID: 23238201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone deficiency and severity of erectile dysfunction are independently associated with reduced quality of life in men with type 2 diabetes.
    Brooke JC; Walter DJ; Kapoor D; Marsh H; Muraleedharan V; Jones TH
    Andrology; 2014 Mar; 2(2):205-211. PubMed ID: 24574152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency.
    Corrales JJ; Almeida M; Miralles JM; Orfao A
    Fertil Steril; 2009 Jul; 92(1):311-9. PubMed ID: 18710716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
    Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
    Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.
    Ho CC; Tong SF; Low WY; Ng CJ; Khoo EM; Lee VK; Zainuddin ZM; Tan HM
    BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone and the heart.
    Hackett G
    Int J Clin Pract; 2012 Jul; 66(7):648-55. PubMed ID: 22698417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low testosterone levels are common and associated with insulin resistance in men with diabetes.
    Grossmann M; Thomas MC; Panagiotopoulos S; Sharpe K; Macisaac RJ; Clarke S; Zajac JD; Jerums G
    J Clin Endocrinol Metab; 2008 May; 93(5):1834-40. PubMed ID: 18319314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus.
    Fukui M; Ose H; Kitagawa Y; Yamazaki M; Hasegawa G; Yoshikawa T; Nakamura N
    Metabolism; 2007 Sep; 56(9):1167-73. PubMed ID: 17697857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency].
    Morgunov LIu; Vertkin AL; Pushkar' DIu
    Urologiia; 2007; (5):49-51. PubMed ID: 18254226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of continuous positive airway pressure therapy on sexual function and serum testosterone in males with type 2 diabetes and obstructive sleep apnoea.
    Knapp A; Myhill PC; Davis WA; Peters KE; Hillman D; Hamilton EJ; Lim EM; Davis TM
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):254-8. PubMed ID: 24392703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a physician-supervised exercise-nutrition program with testosterone substitution in partial androgen-deficient middle-aged obese men.
    Schwarz ER; Willix RD
    J Geriatr Cardiol; 2011 Dec; 8(4):201-6. PubMed ID: 22783306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Testosterone Levels in Patients With and Without Type 2 Diabetes.
    Kumari N; Khan A; Shaikh U; Lobes K; Kumar D; Suman F; Bhutto NS; Anees F; Shahid S; Rizwan A
    Cureus; 2021 Jul; 13(7):e16288. PubMed ID: 34381648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.